Wyeth Hit With $1.5M Verdict In Prempro Case

Law360, New York (January 3, 2011, 3:37 PM EST) -- A federal jury has hit Pfizer Inc. unit Wyeth with $1.5 million in damages in a suit brought by a pharmacist who allegedly developed breast cancer through her use of menopause drug Prempro, marking the end of a recent string of favorable verdicts for the company in Prempro cases.

A jury in the U.S. District Court for the District of Puerto Rico said Thursday that Helen Rivera-Adams had proven she developed breast cancer because of her use of Prempro, and that Wyeth had failed to adequately...
To view the full article, register now.